Overview

A Study to Evaluate the Efficacy and Safety of Meptin® Swinghaler® and Ventolin® MDI in Stable Asthma Patients

Status:
Completed
Trial end date:
2010-06-01
Target enrollment:
Participant gender:
Summary
This is an open-label, randomized, cross-over, active-controlled study to evaluate the efficacy and safety effects using Meptin® Swinghaler and Ventolin® MDI in stable asthma patients.
Phase:
Phase 3
Details
Lead Sponsor:
Taiwan Otsuka Pharm. Co., Ltd
Treatments:
Albuterol
Procaterol